Significance of zoledronic acid on survival in patients with bone metastases from renal cell carcinoma.
Yasuhisa Fujii
No relevant relationships to disclose
Yosuke Yasuda
No relevant relationships to disclose
Takeshi Yuasa
No relevant relationships to disclose
Gen Sukegawa
No relevant relationships to disclose
Shinichi Kitsukawa
No relevant relationships to disclose
Shinji Urakami
No relevant relationships to disclose
Shinya Yamamoto
No relevant relationships to disclose
Junji Yonese
No relevant relationships to disclose
Shunji Takahashi
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Iwao Fukui
No relevant relationships to disclose